Table 3.
TGF Peak | MR Peak | LF Comp. (%) | HF Magn. (%) | TGF Freq. (mHz) | MR Freq. (mHz) | TGF Phase (°) | MR Phase (°) | |
---|---|---|---|---|---|---|---|---|
Full model (full autoregulation) | ✓ | ✓ | 90 | 15 | 45 | 190 | 130 | 90 |
Full model (TFG inhibited) | – | ✓ | 80 | 15 | – | 183 | – | 80 |
Full model (MR inhibited) | ✓ | ✓ | 30 | 15 | 45 | 186 | 135 | 12 |
Simplified model (full autoregulation) | ✓ | ✓ | 90 | 15 | 44 | 183 | 124 | 61 |
Simplified model (TGF inhibited) | – | ✓ | 70 | 15 | – | 177 | – | 49 |
Simplified model (MR inhibited) | ✓ | ✓ | 60 | 15 | 43 | 185 | 180 | 29 |
Ref. Sakai et al. (1986) (normotensive, atrial fibrillation) | ✓ | ✓ | n/a | 10 | 30–100* | 100–250 | n/a | 15 |
Ref. Daniels et al. (1990) (control) | ✓ | ✓ | 70 | 20* | 40–60* | 150* | 45* | 60* |
Ref. Daniels et al. (1990) (obstruction) | – | ✓ | 60 | 20* | – | 150* | – | 45* |
Ref. Holstein-Rathlou et al. (1991) | ✓ | ✓ | 60 | 20 | 30–40 | 150 | 57 | 57* |
Ref. Holstein-Rathlou et al. (1991) (tubular pressure) | ✓ | ✓ | n/a | n/a | 30–40 | 150 | 90* | 30* |
Ref. He and Marsh (1993) (control) | ✓ | ✓ | 70* | n/a | 54 | 100–200 | n/a | n/a |
Ref. Chen and Holstein-Rathlou (1993) (Wistar-Kyoto) | – | ✓ | 70* | 100* | – | 100–140 | - | 70* |
Ref. Janssen et al. (1995) | n/a | ✓ | n/a | 20* | n/a | 200* | n/a | 57* |
Ref. Cupples et al. (1996) (halothane) | ✓ | ✓ | 60* | 30* | 30–50 | 100–150 | n/a | n/a |
Ref. Cupples et al. (1996) (isoflurance) | ✓ | ✓ | 60* | 30* | 30–50 | 150–200 | n/a | n/a |
Ref. Ajikobi et al. (1996) (SD, isoflurane, control) | ✓ | ✓ | 45 | 50* | 50* | 200* | 52 | 46 |
Ref. Ajikobi et al. (1996) (SD, isoflurane, furosemide) | – | ✓ | 31 | 20* | – | n/a | – | 23 |
Ref. Ajikobi et al. (1996) (SD, halothane, control) | ✓ | ✓ | 49 | 50* | 50 | 120* | 114 | 63 |
Ref. Ajikobi et al. (1996) (SD, halothane, furosemide) | – | ✓ | 49 | 20* | – | 120* | – | 63 |
Ref. Karlsen et al. (1997)(S-L) | ✓ | ✓ | n/a | n/a | 40 | 200 | n/a | n/a |
Ref. Karlsen et al. (1997)(R-L) | ✓ | ✓ | n/a | n/a | 30–40* | 200–250* | n/a | n/a |
Ref. Karlsen et al. (1997) (SPD-N) | ✓ | ✓ | n/a | n/a | 50 | 200 | n/a | n/a |
Ref. Just et al. (1998) (control) | ✓ | ✓ | 52 | n/a | 27 | 130 | 45 | 45 |
Ref. Just et al. (1998) (Furo-II) | – | ✓ | 35 | n/a | – | 130* | – | n/a |
Ref. Abu-Amarah et al. (1998) (Wistar, denervated) | ✓ | ✓ | 80* | 0* | 40–60* | 210 | 30* | 45* |
Ref. Abu-Amarah et al. (1998) (Wistar, innervated) | ✓ | ✓ | 80* | 50* | 40–60* | 210* | n/a | 45* |
Ref. Just et al. (1999) (control) | ✓ | ✓ | 60* | n/a | 30 | 150* | n/a | n/a |
Ref. Lessard et al. (1999) (Wistar) | ✓ | ✓ | 70 | n/a | 50* | 260 | 90* | 90* |
Ref. Wang et al. (1999) (control) | ✓ | ✓ | 70* | 30* | 30–50* | 250 | 45* | 60* |
Ref. Wang et al. (2000) (Brown Norway, control) | ✓ | ✓ | 80* | 30* | 40 | 200* | n/a | n/a |
Ref. Wang et al. (2000) (Wistar, control) | ✓ | ✓ | 85* | 30* | 20* | 200* | n/a | n/a |
Ref. Wang and Cupples (2001) (Wistar, control) | ✓ | ✓ | 80* | 80* | 30–40* | 250* | 45* | 45* |
Ref. Wang and Cupples (2001) (Brown Norway, control) | ✓ | ✓ | 60* | 30* | 40* | 200* | 45* | 45* |
Ref. Pires et al. (2001) (intact) | ✓ | ✓ | 80* | 80* | 50 | 250 | 45* | 45* |
Ref. Loutzenhiser et al. (2002) | ✓ | ✓ | 70* | 10* | 40–60* | 250 | 57* | 90* |
Ref. Sandgaard et al. (2002) | ✓ | ✓ | 60* | 120* | 30 | 200 | n/a | n/a |
Ref. Just et al. (2002) (control) | ✓ | ✓ | 50* | 100* | 30 | 100 | n/a | n/a |
Ref. Cupples et al. (2002) (forced, control) | ✓ | ✓ | 70* | 100* | 30–40* | 250 | 45* | 45* |
Ref. Just and Arendshorst (2003) | ✓ | ✓ | n/a | n/a | 30–40 | 100–200 | n/a | n/a |
Ref. Griffin et al. (2004) (control) | ✓ | ✓ | 50* | 60* | 30–60* | 250* | 45* | 90* |
Ref. Knudsen et al. (2004)(Dahl R) | ✓ | ✓ | n/a | n/a | 40 | 200 | n/a | n/a |
Ref. Shi et al. (2006) (control prior furosemide) | ✓ | ✓ | 70* | 100* | 40* | 200* | 86* | 45* |
Ref. Shi et al. (2006) (furosemide) | – | ✓ | 40* | 100* | – | 200* | – | 30* |
Ref. Bell et al. (2006) (control C) | ✓ | ✓ | 50* | 100* | 50* | 200* | n/a | n/a |
Ref. Wang et al. (2007) (100 mmHg) | – | ✓ | 40* | 50* | – | 160 | – | 23* |
Ref. Scully et al. (2013) (control) | – | ✓ | 70* | 100* | – | 180* | – | 68* |
Ref. Moss et al. (2016) (control prior UO) | ✓ | ✓ | 60* | 20* | 20–40* | 200* | n/a | n/a |
Compensation and magnification are given by 1 −|H(f)| and |H(f)| − 1, respectively
“LF comp.” compensation at 1 Hz; “HF magn.” magnification at 1 Hz. n/a indicates values that are not reported or cannot be inferred from the provided data or figures
Values obtained from visual inspection of the provided figures